Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,090 public trials 2,046 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Pembrolizumab (MK-3475) in MM Patients With Residual Disease

NCT02636010

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clinic Barcelona, Spain
  • Hospital 12 de octubre Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
View Trial Details
Completed

ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)

NCT00662948

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Hospital Juan Canalejo A Coruña, Spain
  • Hospital de Alcorcón Alcorcón, Spain
  • Hospital germans Trias i Pujol Badalona, Spain
  • Hospital Clínic Barcelona, Spain
View all 21 locations
View Trial Details
Completed

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

NCT02316197

Conditions
Advanced Solid Tumors, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • Rigshospitalet - Onkologisk KFE Copenhagen, Denmark
  • Herlev Hospital University of Copenhagen Herlev, Denmark
View Trial Details
Completed

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

NCT02783651

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Chicago, Illinois, United States
View all 19 locations
View Trial Details
Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma

NCT02460276

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Norwegian Radium Hospital Oslo, Norway
  • Lund University Hospital Lund, Sweden
View Trial Details

Related conditions